In lung adenocarcinoma patients, two previous studies (39, 40)combined both radiomic and clinical features to successfully build a radiomic-clinical model that could efficiently identify EGFR mutant phenotypes from wild types with good AUCs of 0.779 and 0.823. This evidence concerns the gene EGFR and lung adenocarcinoma.